JosephKasermanMD

Critical Care Medicine, Pleural Disease

Physician

Are you Dr. Kaserman?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 39 invites waiting!
Read the latest clinical news, personalized to your specialty.

Office
725 Albany Street
Shapiro 9 Suite B
Boston, MA 02118
Phone+1 617-638-7480

Fax+1 617-638-7486

Dr. Joseph Kaserman, MD is a pulmonologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and Rhode Island. He is affiliated with Boston Medical Center.

Boston University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2013 - 2017
Brown UniversityResidency, Internal Medicine, 2010 - 2013
University of Vermont College of MedicineClass of 2010

PubMed

Thyroid hormone receptor beta (THRβ1) is the major regulator of T3 action in human iPSC-derived hepatocytes.
Lorraine Soares De Oliveira, Joseph E Kaserman, Anne H Van Der Spek, Nora J Lee, Hendrik J Undeutsch
Molecular Metabolism. 2024-12-01
Disturbed function of TBL1X has a differential effect on T3-regulated gene expression in two human liver cell models.
Yalan Hu, Lorraine Soares De Oliveira, Kim Falize, A S Paul van Trotsenburg, Eric Fliers
European Thyroid Journal. 2024-10-01
4 citations
Human iPSC-hepatocyte modeling of alpha-1 antitrypsin heterozygosity reveals metabolic dysregulation and cellular heterogeneity.
Joseph E Kaserman, Rhiannon B Werder, Feiya Wang, Taylor Matte, Michelle I Higgins
Cell Reports. 2022-12-06

Genetic Mutation Has Increased Risk of Developing Liver Disease, Study RevealsDecember 7th, 2022
Study Finds Mutations That Could Contribute to Increased Liver Disease in Patient PopulationsDecember 6th, 2022
Rare Disease Day 2/28/2018February 26th, 2018
Join now to see all